Pregnancy in patients with systemic lupus erythematosus.
This retrospective study of 31 patients with systemic lupus erythematosus during 38 pregnancies shows a spontaneous or missed abortion rate of 7.9%, elective abortion rate of 10.5%, and a perinatal mortality rate of 12.9%. There was one maternal death 5 weeks post partum. If the onset of systemic lupus erythematosus during pregnancy included nephritis or significant thrombocytopenia, the mothers were acutely ill. All of the perinatal mortality occurred in these patients. Management of systemic lupus erythematosus during pregnancy need not differ from that in the nonpregnant state. However, immunosuppressive therapy should not be diminished or discontinued during pregnancy. Clinical parameters, renal function studies, and hematologic information were far more useful than immunologic laboratory data in assessing the course of systemic lupus erythematosus during pregnancy and indicating alterations in treatment. Antepartum fetal surveillance is advised. The timing of and route of delivery must be individualized, and systemic lupus erythematosus in and of itself is not an indication for delivery by cesarean section.
D000030:Abortion, Missed; D000022:Abortion, Spontaneous; D000208:Acute Disease; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D005323:Fetal Monitoring; D005865:Gestational Age; D006403:Hematologic Tests; D006801:Humans; D007231:Infant, Newborn; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D009393:Nephritis / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications; D011379:Prognosis; D012189:Retrospective Studies; D013246:Sterilization, Tubal; D013921:Thrombocytopenia / Q000209:etiology
D000305:Adrenal Cortex Hormones